Alexion Pharmaceuticals
Biotechnology company; focuses on drugs treating thrombosis and hematological malignancies
Based in CA
AI Overview
With $355K in lobbying spend across 13 quarterly filings, Alexion Pharmaceuticals is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2019 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $10K |
| 2020 | $150K |
| 2021 | $195K |
| 2022 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Alexion Pharmaceuticals disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Health Issues
New Technology Add-on Payment (NTAP) for Medicare; Reimbursement issues related to coding (J code and C code)
Discussed CMS reimbursement and New Technology Add-on Payment(NTAP) for prescription drugs.
Medicare Policy and Reimbursement
S.4010 - Creating Hope Reauthorization Act
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.